Vertex Pharmaceuticals Inc. (VRTX)

Index: Nasdaq 100
-1.36%
-$1.20
$87.64
16:00 29/09/16
$87.64
16:00 29/09/16
DAILY VARIATION
-1.36%
-$1.20
VOLUME
520,748
DATA
52 Week High
$133.26
52 Week Low
$78.40
Shares Issued
247.78m
Market Cap
$21,714.09m
RiskGrade
166
Beta
1.62
MENU

Vertex Pharmaceuticals Inc. Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -45.2% -1.6%
ROCE 0.0%
Latest F'cast
P/E 38.5 9,959.3
PEG -1.5 -1.6
Pr/Revenue 21.3 12.6
Pr/Book 20.1
Latest F'cast
Revenue 77.9% -31.2%
PBT 0.0% n/a
EPS -26.4% -69.7%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2011-12-31 1,410.63 60.44 14.00¢ 237.2 0.0 n/a n/a 0.0%
2012-12-31 1,527.04 -12.38 -50.00¢ -83.8 0.0 n/a n/a 0.0%
2013-12-31 1,211.97 -626.04 -198.00¢ -37.5 0.0 n/a n/a 0.0%
2014-12-31 580.41 -734.88 314.00¢ 37.8 0.0 n/a n/a 0.0%
2015-12-31 1,032.34 -557.80 231.00¢ 54.5 -2.1 -26% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2016-12-31 1,747.00 -27.20 97.01c 9,959.3 -171.7 -58% 0.00c 0.0%
2017-12-31 2,415.48 600.00 298.51c 3,067.0 14.8 208% 0.00c 0.0%

Regulatory News

No results found

Newspaper Links

No results found